Abstract
The symposium “Pharmacogenomics of CNS Disorders” was organized by Dr. Ramón Cacabelos of Euroespes Medical Center, and the four speakers from Japan, China, USA, and Spain presented their data of genomic research concerning CNS disorders. M.Takeda presented the translational approach for development of disease- modifying drugs against Alzheimerʻs disease. YongYong Shi from Peopleʼs Republic of China talked about genetic studies of clozapine- olanzapine- induced side- effects in the Han Chinese population. Gjumrakch Aliev, USA talked on oxidative stress - induced mitochondrial DNA overproliferation and deletion in neurodegenerative disorders. Ramon Cacabelos, Spain, talked about influence of pleiotropic genes in CNS pharmacogenomics. It is important to promote the research toward implementation of personalized medicine in which genomic data of the individual will be utilized for the better selection and better dosing of the drugs for CNS disorders. The pharmacogenomics data is expected to be especially useful for CNS disorders.
